Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Growth Factors”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableUnknownNCT01312220
What this trial is testing

Growth Factors and Hepatic Progenitor Cells in Acute Liver Failure

Who this might be right for
the Focus of the Study is to Correlate the Growth Factors in Serum With the Progenitor Cells in Liver
National Taiwan University Hospital 10
Early research (Phase 1)Study completedNCT00911469
What this trial is testing

Study of AS902330 (rhFGF-18) Administered Intra-articularly in Patients With Knee Primary Osteoarthritis Who Are Candidates for Total Knee Replacement

Who this might be right for
Knee Osteoarthritis
Merck KGaA, Darmstadt, Germany 73
Testing effectiveness (Phase 2)Study completedNCT00001860
What this trial is testing

Sandostatin LAR Depot vs. Surgery for Treating Acromegaly

Who this might be right for
AcromegalyPituitary Neoplasm
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 5
Testing effectiveness (Phase 2)Study completedNCT02646020
What this trial is testing

Aprepitant vs. Desloratadine in EGFR-TKIs Related Pruritus Treatment

Who this might be right for
Non-small Cell Lung Cancer
Sun Yat-sen University 138
Large-scale testing (Phase 3)Study completedNCT00101582
What this trial is testing

Palifermin for the Reduction of Oral Mucositis in Patients With Locally Advanced Head and Neck Cancer

Who this might be right for
MucositisSolid TumorsStomatitis+2 more
Swedish Orphan Biovitrum 188
Not applicableStudy completedNCT04983420
What this trial is testing

Effects of Different Polyphenol-containing Beverages on the Immune System and on Muscular Growth Factors

Who this might be right for
Food Sensitivity
Balgrist University Hospital 20
Large-scale testing (Phase 3)Active Not RecruitingNCT03690388
What this trial is testing

Cabozantinib Compared With Placebo in Subjects With Radioiodine-refractory Differentiated Thyroid Cancer Who Have Progressed After Prior Vascular Endothelial Growth Factor Receptor (VEGFR) -Targeted Therapy

Who this might be right for
Differentiated Thyroid Cancer
Exelixis 187
Not applicableUnknownNCT03324022
What this trial is testing

Observing the Relationship of Fibroblast Growth Factor and Fibroblast in Thyroid Eye Disease

Who this might be right for
Graves Ophthalmopathy
National Taiwan University Hospital 80
Testing effectiveness (Phase 2)Study completedNCT00633750
What this trial is testing

Erlotinib in Treating Patients With Breast Cancer That Can Be Removed by Surgery

Who this might be right for
Breast Cancer
Vanderbilt-Ingram Cancer Center 50
Post-approval studies (Phase 4)Study completedNCT01203917
What this trial is testing

Efficacy, Safety, Tolerability of Gefitinib as 1st Line in Caucasian Patients With EGFR Mutation Positive Advanced NSCLC

Who this might be right for
Caucasian Patients With EGFR Mutation Positive Advanced NSCLC
AstraZeneca 1,060
Early research (Phase 1)Temporarily pausedNCT05887882
What this trial is testing

Intra-Tumoral Injections of Natural Killer Cells for Recurrent Malignant Pediatric Brain Tumors

Who this might be right for
Pediatric Brain TumorRecurrent Pediatric Brain TumorPediatric Neoplasm
Sabine Mueller, MD, PhD 24
Testing effectiveness (Phase 2)Active Not RecruitingNCT06391944
What this trial is testing

JMT101 Combined With Osimertinib in Patients With Stage Ⅲb-Ⅳ Non-small Cell Lung Cancer (NSCLC) Characterized by Epithermal Growth Factor Receptor (EGFR) Common Mutations

Who this might be right for
Local Advanced or Metastatic NSCLCHarboring EGFR Common Mutation
Shanghai JMT-Bio Inc. 161
Not applicableStudy completedNCT01465399
What this trial is testing

Plasma Rich in Growth Factors (PRGF-Endoret) in the Regeneration of Post-Extraction Sockets

Who this might be right for
Post-Extraction Sockets Healing
Fundación Eduardo Anitua 60
Not applicableStudy completedNCT00848185
What this trial is testing

Differential Regulation of VEGF, Cadherin, Angiopietin 2 by Trigger Oocyte Maturation With GnRHa vs hCG in Donors

Who this might be right for
Vascular Endothelial Growth Factor Overexpression
IVI Madrid 96
Large-scale testing (Phase 3)Study completedNCT02447510
What this trial is testing

Growth Factors Release of PRF and PRGF

Who this might be right for
Periodontitis
Al-Azhar University 30
Not applicableStudy completedNCT02169349
What this trial is testing

Molecular Diagnosis on Circulating Tumor DNA of Non-Small Cell Lung Cancer

Who this might be right for
Stage IIIb and IV Non Small Cell Lung Cancer
Rennes University Hospital 100
Early research (Phase 1)Study completedNCT00276055
What this trial is testing

Phase IB Study of Gemcitabine, Docetaxel and Bevacizumab in Patients With Soft Tissue Sarcoma

Who this might be right for
Sarcoma
New Mexico Cancer Research Alliance 38
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06577376
What this trial is testing

A PhaseⅠ/Ⅱ Study of Simmitinib or Irinotecan Liposomes Combined With DP303c in Gastric Adenocarcinoma or Gastroesophageal Junction Adenocarcinoma

Who this might be right for
Localized Advanced or Metastatic Gastric Adenocarcinoma or Gastroesophageal Junction AdenocarcinomaExpressing Human Epidermal Growth Factor Receptor-2 (HER-2)Disease Progression After Receiving at Least One and at Most Two Lines of Systemic Treatment in the Past
Shanghai Runshi Pharmaceutical Technology Co., Ltd
Post-approval studies (Phase 4)WithdrawnNCT02707120
What this trial is testing

Efficacy and Safety of Plasma Rich in Growth Factors (PRGF-Endoret) Eye-drops in the Treatment of Neurotrophic Keratitis

Who this might be right for
Neurotrophic Keratitis
Biotechnology Institute IMASD
Not applicableStudy completedNCT01447043
What this trial is testing

Study to Assess the Effectiveness of Existing Anti vascUlar Endothelial Growth Factor (Anti VEGF) in Patients With Wet Age-related Macular Degeneration (wAMD) (AURA)

Who this might be right for
Ophthalmology, Macular Degeneration
Bayer 2,609
Next Page
252